EcoDrugPlus

Integrin Subunit Beta 1

Ensembl ID : ENSTRUG00000028451
Gene Symbol: ITGB1
1 Cross references
227 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSTRUG00000003505
Gene Symbol: ITGB1
1 Cross references
227 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSTRUG00000015838
Gene Symbol: ITGB5
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSTRUG00000020431
Gene Symbol: ITGB6
4 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSTRUG00000007871
Gene Symbol: ITGB8
2 Cross references
202 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSTRUG00000000741
Gene Symbol: ITGAV
1 Cross references
237 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSTRUG00000025150
Gene Symbol: IRAK4
4 Cross references
202 Possible Orthologues:

Interleukin-6

Ensembl ID : ENSTRUG00000008735
Gene Symbol: IL-6
3 Cross references
162 Possible Orthologues:

Intermediate Conductance Calcium-Activated Potassium Channel Protein 4-Like

Ensembl ID : ENSTRUG00000015090
Gene Symbol: LOC101072171
2 Cross references
187 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSTRUG00000003000
Gene Symbol: LOC101075877
4 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSTRUG00000005863
Gene Symbol: IDH1
1 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSTRUG00000002406
Gene Symbol: IDH2
1 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).